Mercia sells stake in Covid-19 antigen producer in GBP18 million deal
Specialist asset manager, Mercia Asset Management, has sold its stake in The Native Antigen Company, a leading producer of infectious disease reagents, to global life sciences tools company LGC for a total cash consideration of up to GBP18.0 million.Mercia has supported The Native Antigen Company since it commenced trading, investing from